FDA Gives Moderna COVID Vaccine Full Approval
MONDAY, Jan. 31, 2022 (HealthDay News) — Moderna’s COVID-19 vaccine has received full approval for use in people 18 and older, the U.S. Food and Drug Administration announced Monday. The vaccine, which has been available for that age group under emergency use authorization (EUA), will be marketed as Spikevax. It’sContinue Reading